GNS.L

Genus Plc
Genus - Director/PDMR Shareholding
16th September 2024, 15:29
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3881E
Genus PLC
16 September 2024
 

16 September 2024

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vestings on 23 February 2024 and 2 May 2024 of nil-cost options granted on 2 May 2023 over ordinary shares pursuant to Listing Rule 9.4.2R, as listed in table A below, Jorgen Kokke, Chief Executive Officer sold ordinary shares in Genus on 16 September 2024 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercise of those vested options and retained the balance of ordinary shares.

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 16 September 2024.

 

For further information please contact:

 

Genus:

Cara Guedeney, Deputy Company Secretary                                      Tel: +44 (0)1256 347100

 

 

 

Table A - Exercise of buy-out awards vesting on 23 February 2024

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Jorgen Kokke

2.            

Reason for the notification

a.            

Position/status

Chief Executive

b.            

Initial notification

/Amendment

Initial notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.           

LEI

54930022EOITNKSIGH56

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.            

Nature of the transaction

Exercise of nil-cost options granted on 2 May 2023 under Listing Rule 9.4.2R over ordinary shares in Genus.

 

c.            

Price(s) and volume(s)

 

Price

Volume

0p

59,055

      

d.            

Aggregated information

·    Aggregated volume

·    Price

 

Price(s)

Volume(s)

0p

59,055

e.            

Date of the transaction

2024-09-16

f.            

Place of the transaction

Outside a trading venue.

5.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under Listing Rule 9.4.2R to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price

Volume

1,956.97p

16,876

      

d.

Aggregated information

·    Aggregated volume

·    Price

 

 

Price

Volume

1,956.97p

16,876

e.

Date of the transaction

2024-09-16

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

Table B - Exercise of buy-out awards vesting on 2 May 2024

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

 

2.   

Reason for the notification

a.            

Position/status

Chief Executive Director

b.            

Initial notification

/Amendment

Initial notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.           

LEI

54930022EOITNKSIGH56

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.            

Nature of the transaction

Exercise of nil-cost options granted under Listing Rule 9.4.2R over ordinary shares in Genus.

c.            

Price(s) and volume(s)

 

Price

Volume

0p

7,649

      

d.            

Aggregated information

·    Aggregated volume

·    Price

 

Price

Volume

0p

7,649

e.            

Date of the transaction

2024-09-16

f.            

Place of the transaction

Outside a trading venue.

5.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under Listing Rule 9.4.2R to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

1,956.00p

2,186

      

d.

Aggregated information

·    Aggregated volume

·    Price

 

Numbers 1 to 6 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

Volume(s)

1,956.00p

2,186

e.

Date of the transaction

2024-09-16

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUNUVRSWUKAAR]]>
TwitterFacebookLinkedIn